Literature DB >> 18418029

Behavioral conditioning of antihistamine effects in patients with allergic rhinitis.

Marion U Goebel1, Nuschin Meykadeh, Wei Kou, Manfred Schedlowski, Ulrich R Hengge.   

Abstract

BACKGROUND: Allergic symptoms can be induced by behavioral conditioning. However, the conditionability of antiallergic effects has not yet been studied. Thus, we investigated whether the effects of a histamine 1 (H(1)) receptor antagonist are inducible in patients suffering from house-dust mite allergy using a behavioral conditioning procedure.
METHODS: During the association phase, 30 patients with allergic house-dust mite rhinitis received a novel-tasting drink once daily, followed by a standard dose of the H(1) receptor antagonist, desloratadine, on 5 consecutive days. After 9 days of drug washout, the evocation trial commenced: 10 patients received water together with an identically looking placebo pill (water group), 11 patients were re-exposed to the novel-tasting drink and received a placebo pill [conditioned stimulus (CS); CS group] and 9 patients received water and desloratadine (drug group).
RESULTS: During the association phase, desloratadine treatment decreased the subjective total symptom scores, attenuated the effects of the skin prick test for histamine and reduced basophil activation ex vivo in all groups. During the evocation trial, the water group, in which subjects were not re-exposed to the gustatory stimulus, showed a reduction in subjective total symptom scores and skin prick test results, but no inhibition of basophil activation. In contrast, re-exposure to the novel-tasting drink decreased basophil activation, the skin prick test result and the subjective symptom score in the CS group to a degree that was similar to the effects of desloratadine in the drug group.
CONCLUSIONS: These data show that behaviorally conditioned effects are not only able to relieve subjective rhinitis symptoms and allergic skin reactions, but also to induce changes in effector immune functions. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418029     DOI: 10.1159/000126074

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  30 in total

1.  The Placebo Effect in Pain Therapies.

Authors:  Luana Colloca
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-14       Impact factor: 13.820

Review 2.  The placebo effect and the autonomic nervous system: evidence for an intimate relationship.

Authors:  Karin Meissner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 3.  Behavioural conditioning as the mediator of placebo responses in the immune system.

Authors:  Sabine Vits; Elvir Cesko; Paul Enck; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  [Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens].

Authors:  B Wedi; D Wieczorek; A Kapp
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

Review 5.  Role of placebo effects in pain and neuropsychiatric disorders.

Authors:  Annabelle M Belcher; Sergi Ferré; Pedro E Martinez; Luana Colloca
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-06-14       Impact factor: 5.067

Review 6.  [Placebo and nocebo effects on itch : Methodological and clinical implications].

Authors:  J Tekampe; K J Peerdeman; D J P Bartels; A I M van Laarhoven; A W M Evers
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

Review 7.  The placebo response in medicine: minimize, maximize or personalize?

Authors:  Paul Enck; Ulrike Bingel; Manfred Schedlowski; Winfried Rief
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

8.  Plasma cortisol response cannot be classically conditioned in a taste-endocrine paradigm in humans.

Authors:  Liubov Petrakova; Karoline Boy; Marisa Kügler; Sven Benson; Harald Engler; Lars Möller; Manfred Schedlowski
Journal:  Psychopharmacology (Berl)       Date:  2017-08-13       Impact factor: 4.530

Review 9.  How placebos change the patient's brain.

Authors:  Fabrizio Benedetti; Elisa Carlino; Antonella Pollo
Journal:  Neuropsychopharmacology       Date:  2010-06-30       Impact factor: 7.853

Review 10.  The placebo effect in asthma.

Authors:  Stefanie Dutile; Ted J Kaptchuk; Michael E Wechsler
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.